This was the stock's fourth consecutive day of losses.
This was the stock's third consecutive day of losses.
Zacks Investment Research on MSN1d
Here's Why DXC Technology Company. (DXC) is a Strong Value StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Marketers and their teams doing business as usual, while dabbling with different tools and dashboards, will not be enough to ...
Medical Device Network on MSN3d
FDA clears Beckman Coulter’s DxC 500i Clinical AnalyzerThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...
DXC Technology's stock has seen a negative 40% return over the past decade, despite the generative AI boom. Explore more details here.
Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an ...
ASHBURN, VA, Feb. 25, 2025 /PRNewswire/ - DXC Technology, (NYSE: DXC), a leading Fortune 500 global technology services provider, has signed an agreement with Skanska AB, a multinational construction ...
ServiceNow and DXC expand their strategic partnership to combine DXC's industry-leading software and expertise with ...
Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...
ServiceNow and DXC expand their strategic partnership to combine DXC's industry-leading software and expertise with ServiceNow's AI-enabled platform ASHBURN, Va. and SANTA CLARA, Calif., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback